Projecting the direct cost burden of osteoarthritis in Canada using a microsimulation model.
暂无分享,去创建一个
J. Kopec | N. Bansback | P. Finès | A. Anis | M. M. Rahman | H. Wong | W. Flanagan | N Bansback | B Sharif | J Kopec | M M Rahman | W M Flanagan | H Wong | P Fines | A Anis | B. Sharif | M. M. Rahman | M. M. Rahman | M. M. Rahman
[1] R. Payton. The Facts , 1984, The Divide.
[2] P Tugwell,et al. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. , 2007, Osteoarthritis and cartilage.
[3] Wan Yongf. The economics of osteoarthritis , 2011 .
[4] Linda C. Li,et al. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study , 2004, Annals of the rheumatic diseases.
[5] S. Popova,et al. Economic Cost of Chronic Disease in Canada 1995-2003 , 2007 .
[6] R. Bitton. The economic burden of osteoarthritis. , 2009, The American journal of managed care.
[7] D. Hunter,et al. Transforming osteoarthritis care in an era of health care reform. , 2010, Clinics in geriatric medicine.
[8] C. Hayes,et al. Use of a Validated Algorithm to Judge the Appropriateness of Total Knee Arthroplasty in the United States: A Multicenter Longitudinal Cohort Study , 2014, Arthritis & rheumatology.
[9] P Tugwell,et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. , 2008, Osteoarthritis and cartilage.
[10] Mark A. Wynne,et al. The consumer price index , 1994 .
[11] J. Katz,et al. Total joint replacement in osteoarthritis. , 2006, Best practice & research. Clinical rheumatology.
[12] James G Wright,et al. The effect of education and income on need and willingness to undergo total joint arthroplasty. , 2002, Arthritis and rheumatism.
[13] Michael H Weisman,et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. , 2006, The New England journal of medicine.
[14] A. Mushlin,et al. Evaluation of Two Appropriateness Criteria for Total Knee Replacement , 2014, Arthritis care & research.
[15] A David Paltiel,et al. Lifetime Medical Costs of Knee Osteoarthritis Management in the United States: Impact of Extending Indications for Total Knee Arthroplasty , 2015, Arthritis care & research.
[16] True difference or something else? Problems in cost of osteoarthritis studies. , 2007, Seminars in arthritis and rheumatism.
[17] Ping Zhang,et al. Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[18] Nigel Rice,et al. The evaluation of health policies through dynamic microsimulation methods , 2011 .
[19] V. Robertson,et al. Predicting risk of extended inpatient rehabilitation after hip or knee arthroplasty. , 2003, The Journal of arthroplasty.
[20] Bernadette A. Thomas,et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[21] Eric J Feuer,et al. Dynamic Microsimulation Models for Health Outcomes , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.
[22] P. Coyte,et al. Costs and outcomes associated with alternative discharge strategies following joint replacement surgery: analysis of an observational study using a propensity score. , 2000, Journal of health economics.
[23] M. Dibonaventura,et al. Impact of self-rated osteoarthritis severity in an employed population: Cross-sectional analysis of data from the national health and wellness survey , 2012, Health and Quality of Life Outcomes.
[24] Nigel Rice,et al. The evaluation of health policies through microsimulation methods , 2010 .
[25] Estimating medical costs attributable to osteoarthritis in the US population: comment on the article by Kotlarz et al. , 2010, Arthritis and rheumatism.
[26] M. Hiligsmann,et al. Development and validation of a Markov microsimulation model for the economic evaluation of treatments in osteoporosis. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[27] The Social Discount Rate for Canada Based on Future Growth in Consumption , 2010 .
[28] G. Hawker,et al. The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition. , 2005, Rheumatology.
[29] A D Paltiel,et al. Disease-modifying drugs for knee osteoarthritis: can they be cost-effective? , 2009, Osteoarthritis and cartilage.
[30] C. Helmick,et al. Medical care expenditures and earnings losses among persons with arthritis and other rheumatic conditions in 2003, and comparisons with 1997. , 2007, Arthritis and rheumatism.
[31] Alan Brennan,et al. Computer Modeling of Diabetes and Its Complications , 2007, Diabetes Care.
[32] E M Badley,et al. Development of a population-based microsimulation model of osteoarthritis in Canada. , 2010, Osteoarthritis and cartilage.
[33] C. Mullins,et al. Cost-of-illness studies : a review of current methods. , 2006, PharmacoEconomics.
[34] R. Goeree,et al. The excess burden of osteoarthritis in the province of Ontario, Canada. , 2012, Arthritis and rheumatism.
[35] Wei Zhang,et al. Obesity and overweight in Canada: an updated cost‐of‐illness study , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[36] A. Anis,et al. The Cost of Hospital Care in Canada: A Comparison of Two Alternatives , 2005, Healthcare management forum.
[37] David J. Vanness,et al. The need for microsimulation to evaluate osteoporosis interventions , 2005, Osteoporosis International.